{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:10:28Z","timestamp":1791274228148,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.medcli.2024.07.021","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:47:11Z","timestamp":1729097231000},"page":"600-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis"],"prefix":"10.1016","volume":"163","author":[{"given":"Luc\u00eda","family":"Est\u00e9vez Asensio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoraida","family":"Verde Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Velasco-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Fern\u00e1ndez-Araque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sainz-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.07.021_bib0155","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s11255-014-0839-2","article-title":"Hyponatremia: pathophysiology, classification, manifestations and management","volume":"46","author":"Rondon-Berrios","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.medcli.2024.07.021_bib0160","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/endrev\/bnad010","article-title":"Syndrome of inappropriate antidiuresis: from pathophysiology to management","volume":"44","author":"Warren","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.medcli.2024.07.021_bib0165","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.3390\/jcm11195810","article-title":"Pathophysiology of drug-induced hyponatremia","volume":"11","author":"Kim","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2024.07.021_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.medcli.2024.07.021_bib0175","unstructured":"The Spanish Agency of Medicines and Medical Devices (AEMPS). Annual Report of the Spanish Pharmacovigilance System for Medicinal Products for Human Use (SEFV-H) - 2020 [Informe Anual del Sistema Espa\u00f1ol de Farmacovigilancia de Medicamentos de Uso Humano (SEFV-H) - 2020] https:\/\/www.aemps.gob.es\/vigilancia\/medicamentosUsoHumano\/SEFV-H\/docs\/resumen_actividad_SEFVH-2020.pdf"},{"key":"10.1016\/j.medcli.2024.07.021_bib0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-20-1374","article-title":"Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls","volume":"184","author":"Atila","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2024.07.021_bib0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/jgs.13325","article-title":"Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study","volume":"63","author":"Nigro","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.medcli.2024.07.021_bib0190","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cpt.1562","article-title":"Severe hyponatremia is often drug induced: 10-year results of a prospective pharmacovigilance program","volume":"106","author":"Ram\u00edrez","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.medcli.2024.07.021_bib0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.maturitas.2013.08.010","article-title":"Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study","volume":"76","author":"Mannesse","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.medcli.2024.07.021_bib0200","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11255-015-1134-6","article-title":"Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome","volume":"47","author":"Tasdemir","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.medcli.2024.07.021_bib0205","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00228-020-03086-6","article-title":"Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia","volume":"77","author":"Mannheimer","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.medcli.2024.07.021_bib0210","first-page":"35","article-title":"Reversible stroke-like symptoms with severe hyponatremia","volume":"106","author":"Holloman","year":"2013","journal-title":"Tenn Med J Tenn Med Assoc"},{"key":"10.1016\/j.medcli.2024.07.021_bib0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7861\/clinmed.22-4-s41","article-title":"Amlodipine induced hyponatraemia","volume":"22","author":"Tun","year":"2022","journal-title":"Clin Med"},{"key":"10.1016\/j.medcli.2024.07.021_bib0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1007708831545","article-title":"Hyponatremia and amlodipine therapy","volume":"13","author":"Malaterre","year":"1999","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.medcli.2024.07.021_bib0225","doi-asserted-by":"crossref","DOI":"10.3389\/fdsfr.2023.1323057","article-title":"Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems","volume":"3","author":"Cutroneo","year":"2024","journal-title":"Front Drug Saf Regul"},{"key":"10.1016\/j.medcli.2024.07.021_bib0230","first-page":"699","article-title":"Hyponatremia and confusion caused by pregabalin","volume":"11","author":"Blum","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.medcli.2024.07.021_bib0235","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.revmed.2012.08.013","article-title":"Trouble de la marche r\u00e9v\u00e9lant un syndrome de s\u00e9cr\u00e9tion inappropri\u00e9e d\u2019hormone antidiur\u00e9tique associ\u00e9 \u00e0 la pr\u00e9gabaline","volume":"33","author":"Haddad","year":"2012","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.medcli.2024.07.021_bib0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5049\/EBP.2016.14.2.31","article-title":"A case report of syndrome of inappropriate antidiuretic hormone induced by pregabalin","volume":"14","author":"Jung","year":"2016","journal-title":"Electrolyte Blood Press"},{"key":"10.1016\/j.medcli.2024.07.021_bib0245","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/bcp.13256","article-title":"Medication-induced SIADH: distribution and characterization according to medication class","volume":"83","author":"Shepshelovich","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.medcli.2024.07.021_bib0250","first-page":"45","article-title":"Pregabalin induced syndrome of inappropriate anti-diuretic hormone (SIADH) secretion: a case report","volume":"10","author":"Metwali","year":"2019","journal-title":"J Basic Clin Pharm"},{"key":"10.1016\/j.medcli.2024.07.021_bib0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/11319070-000000000-00000","article-title":"Antipsychotic-induced hyponatraemia: a systematic review of the published evidence","volume":"33","author":"Meulendijks","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.medcli.2024.07.021_bib0260","article-title":"Paliperidone inducing concomitantly syndrome of inappropriate antidiuretic hormone, neuroleptic malignant syndrome, and rhabdomyolysis","volume":"2016","author":"Kaur","year":"2016","journal-title":"Case Rep Crit Care"},{"key":"10.1016\/j.medcli.2024.07.021_bib0265","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.16l02088","article-title":"Paliperidone-induced hyponatremia","volume":"19","author":"Tibrewal","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.medcli.2024.07.021_bib0270","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/1060028017708324","article-title":"Hyponatremia associated with once-monthly paliperidone palmitate use","volume":"51","author":"Isaacs","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.medcli.2024.07.021_bib0275","first-page":"848","article-title":"The syndrome of inappropriate diuretic hormone secretion (SIADH) ending lethal during the use of paliperidon and lamotrigine","volume":"60","author":"Monden","year":"2018","journal-title":"Tijdschr Voor Psychiatr"},{"key":"10.1016\/j.medcli.2024.07.021_bib0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/JCP.0000000000001180","article-title":"Paliperidone-associated hyponatremia: report of a fatal case with analysis of cases reported in the literature and to the US Food and Drug Administration adverse event reporting system","volume":"40","author":"Mazhar","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.medcli.2024.07.021_bib0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijid.2005.11.002","article-title":"Hyponatraemia associated with lopinavir\u2013ritonavir?","volume":"11","author":"Roberts","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medcli.2024.07.021_bib0290","unstructured":"The Spanish Agency of Medicines and Medical Devices (AEMPS) [Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS)]. Precautionary immobilisation of all lots of Atosiban Normon [Inmovilizaci\u00f3n cautelar de todos los lotes de Atosiban Normon]. https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2013\/ni-muh_fv_24-2013-atosiban\/."},{"key":"10.1016\/j.medcli.2024.07.021_bib0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/1097-0142(19850101)55:1<44::AID-CNCR2820550107>3.0.CO;2-B","article-title":"Syndrome of inappropriate antidiuretic hormone secretion. A complication of high-dose intravenous melphalan","volume":"55","author":"Greenbaum-Lefkoe","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2024.07.021_bib0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40264-015-0351-3","article-title":"An empirical approach to explore the relationship between measures of disproportionate reporting and relative risks from analytical studies","volume":"39","author":"Maci\u00e1-Mart\u00ednez","year":"2016","journal-title":"Drug Saf"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324005530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324005530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:51:34Z","timestamp":1733856694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324005530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0025775324005530"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.07.021","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}